Potentiation of the response to chemotherapy in patients with breast cancer by dietary supplementation with L-arginine: Results of a randomised controlled trial

International Journal of Oncology

Volumn 12, Issue 1, 1998, Pages 221-225

  Heys, Steven D ^a,c   Ogston, Keith ^a   Miller, Ian ^a   Hutcheon, Andrew W ^a   Walker, Leslie G ^a   Sarker, Tarun K ^a   Dewar, John ^b   Ah See, Antoine K ^b   Eremin, Oleg ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b Department of Clinical Oncology ^*

^c ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

Breast cancer; Chemotherapy; L arginine; Randomised controlled trial

Indexed keywords

ANTINEOPLASTIC AGENT; ARGININE; CYCLOPHOSPHAMIDE; DOXORUBICIN; PLACEBO; PREDNISOLONE; VINCRISTINE; CHOP PROTOCOL; PREDNISONE;

ADULT; AGED; ALOPECIA; ANEMIA; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG POTENTIATION; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; NEUTROPENIA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; ADENOCARCINOMA; ADJUVANT THERAPY; BREAST TUMOR; CANCER STAGING; COMPARATIVE STUDY; LUNG CARCINOMA; MASTECTOMY; METABOLISM; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ARGININE; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CYCLOPHOSPHAMIDE; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; DOXORUBICIN; DRUG SYNERGISM; FEMALE; HUMANS; MASTECTOMY; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PREDNISONE; RADIOTHERAPY, ADJUVANT; VINCRISTINE;

EID: 0031974832     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.12.1.221     Document Type: Article

References (24)

1. Heys SD, Eremin J, Sarkar TK, Hutcheon AW, Ah-See AK and Eremin O: Role of multimodality therapy in the management of locally advanced breast cancer. J Am Coll Surg 179: 493-504, 1994.
2. Bonadonna G, Valagussa P, Branbilla C, et al: Pre-operative chemotherapy in operable breast cancer. Lancet 341: 1485, 1993.
3. Miller AB, Hoogstraten B, Staquet M, et al: Reporting results of cancer treatment. Cancer 47: 207-214, 1981.
4. Heys SD, Sarkar TK, Ah-See AK, Eremin JM, Brittenden J and Eremin O: Multimodality therapy in the management of locally advanced breast cancer. J Roy Coll Surg Ed 38: 9-15, 1993.
5. Bonadonna G, Veronesi U, Brambilla C, et al: Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more. J Natl Cancer Inst 82: 1539-1545, 1989.
6. Hortobagyi GN, Ames FC, Buzdar AU, et al: Management of stage III primary breast cancer with primary chemotherapy, surgery and radiation therapy. Cancer 62: 2501-2506, 1988.
7. Gazet J-C, Coombes RC, Ford HT, et al: Assessment of the effect of pretreatment with neo-adjuvant therapy on primary breast cancer. Br J Cancer 73: 758-762, 1996.
8. 4) breast cancer. Cancer Chemother Pharmacol 1: 53-59, 1978.
9. Feldman LD, Hortobagyi GN, Buzdar AU, et al: Pathological assessment of response to induction chemotherapy in breast cancer. Cancer Res 46: 2578-2581, 1986.
10. Luboinski G, Nagadowska M and Pienkowski T: Pre-operative chemotherapy in primarily inoperable cancer of the breast. Eur J Surg Oncol 17: 603-607, 1991.
11. Sorace RA, Bagley CS, Lichter AS, et al: The management of non-metastatic locally advanced breast cancer using primary induction chemotherapy with hormonal synchronization followed by radiation therapy with or without debulking surgery. World J Surg 9: 775-785, 1985.
12. Smith IE, Walsh G, Jones A, et al: High complete remission rates with primary neo-adjuvant infusion chemotherapy for large early breast cancer. J Clin Oncol 13: 424-429, 1995.
13. Torosian MH, Mullen JL, Stein TP, et al: Enhanced tumor response to cycle-specific chemotherapy by pulse total parenteral nutrition. J Surg Res 39: 103-112, 1985.
14. Reynolds HM, Daly JM, Rowlands BJ, et al: Effects of nutritional repletion on host and tumor response to chemotherapy. Cancer 45: 3069-3074, 1980.
15. Remvikos Y, Beuzeboc A, Zajdela A, Voillment N, Magdelenat H and Pouillant P: Correlation of pre-treatment proliferative activity of breast cancer with the response to cytotoxic chemotherapy. J Natl Cancer Inst 81: 1383-1387, 1989.
16. Park KGM, Heys SD, Blessing K, Eremin O and Garlick PJ: Stimulation of human breast cancers, in vivo, by dietary L-arginine. Clin Sci 82: 413-417, 1992.
17. Brittenden J, Heys SD, Miller I, et al: Dietary supplementation with L-arginine in patients with breast cancer (>4 cm) receiving multi-modality treatment: report of a feasibility study. Br J Cancer 69: 918-921, 1994.
18. Heys SD, Park KGM, Garlick PJ and Eremin O: Nutrition and malignant disease: implications for surgical practice. Br J Surg 79: 614-623, 1992.
19. Torosian MH, Mullen JL, Miller EE, Wagner KM, Stein TP and Buzby GP: Adjuvant, pulse total parental nutrition and tumour response to cycle-specific and cycle non-specific chemotherapy. Surgery 94: 291-299, 1983.
20. Teicher BA, Lazo JS and Sartorelli AC: Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells. Cancer Res 41: 73-81, 1981.
21. Alagoz T, Buller RE, Anderson B, et al: Evaluation of hyperbaric oxygen as a chemosensitizer in the treatment of epithelial ovarian cancer in xenografts in mice. Cancer Res 75: 2313-2322, 1995.
22. Andrade SP, Hart IR and Piper PJ: Inhibitors of nitric oxide synthase selectively reduce flow in tumour-associated neovasculature. Br J Pharmacol 107: 1092-1095, 1992.
23. Meyer RE, Shan S, DeAngelo J, et al: Nitric oxide synthase inhibition irreversibly decreases perfusion in the R3230Ac rat mammary adenocarcinoma. Br J Cancer 71: 1169-1174, 1995.
24. Rubens RD: The management of locally advanced breast cancer. Br J Cancer 65: 145-147, 1992.